In a report published Wednesday, BTIG Research analyst April Scee initiated coverage on Nu Skin Enterprises NUS with a Neutral rating.
In the report, BTIG Research noted, “China must regain momentum to support growth and sentiment likely to remain negative until distributor levels rise, which will take time. We don't see NUS regaining $1bn in China during projection period. We also worry about innovation after underwhelming launches. Further, model sensitive to inventory issues, which may repeat if launches weak. Initiate with Neutral.”
Nu Skin Enterprises closed on Tuesday at $39.28.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in